Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Nektar Therapeutics (NKTR): Q1 EPS of -$0.36 misses by $0.03. Revenue of $17.9M (+58% Y/Y). (PR)

  • Wednesday, May 2, 2012, 6:44 PM ET
    Nektar Therapeutics (NKTR): Q1 EPS of -$0.36 misses by $0.03. Revenue of $17.9M (+58% Y/Y). (PR)
Other date
DJIA (DIA) S&P 500 (SPY)